An FDA panel voted to recommend Pfizer’s COVID-19 booster shots for people who are 65 and older or considered high risk. The panel had initially rejected Pfizer’s request for full approval of a third vaccine dose. Here’s what you need to know.
More people died of drug-resistant bacterial infections in 2019 than HIV or malaria, new study suggests
3 hours ago
5 hours ago
Online Abortion Provider and “Activist Physician” Michele Gomez Is Expanding Early Abortion Options Into Primary Care
6 hours ago